Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Breast Cancer: Public Health Impact

DCEG research on breast cancer has made a significant impact in the following areas:

Hereditary Breast Cancer

DCEG studies in hereditary breast and ovarian cancer uncovered the value of risk-reducing salpingo-oophorectomy, now considered a standard-of-care treatment option in the management of women in high-risk families (Tobacman et al., 1982; Struewing et al., 1995; Kramer et al., 2005; Greene et al., 2008, 2011).

A DCEG study of BRCA1 and BRCA2 alterations in the Ashkenazi Jewish population of Washington, D.C., reported lower penetrance for breast and ovarian cancers than earlier studies in families with hereditary breast cancer. The findings highlighted the importance of population-specific founder mutations in genetic testing and affected the clinical management of mutation carriers (Struewing et al., 1997).

Risk Prediction

DCEG researchers developed the Gail breast cancer risk assessment model (Gail et al., 1989) to estimate a woman's risk of developing invasive breast cancer. Since its original publication, the tool has been updated and expanded. It is widely used by clinicians and researchers. The Food and Drug Administration guidelines rely on the tool for the recommendation of use of tamoxifen and raloxifene for breast cancer risk reduction.

Tumor Heterogeneity

Composite image showing a circular tissue section and multiple rows of small, circular red dots above it. The tissue section appears in shades of blue and gray and the red dots are organized in a grid-like pattern.

DCEG researchers conducted epidemiological studies using tumor tissue microarrays that revealed the heterogeneity of breast cancer in terms of risk factors and prognosis (García- Closas et al., 2006, 2008; Yang et al., 2007), which has enhanced clinical care decisions.

Breast Cancer: Full list of article citations

Learn about our current research on breast cancer

Email